Jacobs Levy Equity Management’s HOOKIPA Pharma HOOK Stock Holding History

Jacobs Levy Equity Management’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-33,289	Closed	-$776K	–	1028
2021 Q4	$776K	Buy	33,289 +16,245	+95%	+$653K	0.01%	780
2021 Q3	$1M	Buy	+17,044	New	+$1.24M	0.01%	748

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jacobs Levy Equity Management's HOOK Position: Q1 2022 in Review

Jacobs Levy Equity Management sold out of HOOKIPA Pharma (HOOK) in Q1 2022, closing a stake of 33,289 shares — an estimated $776K sold.

Jacobs Levy Equity Management first reported a position in HOOK in Q3 2021 and held it in 2 quarters. The position peaked at $1M in Q3 2021. 74 funds tracked by Wall St. Rank hold HOOK as of Q1 2022.

Jacobs Levy Equity Management reported no remaining HOOKIPA Pharma position as of Q1 2022 after selling out during the quarter.
Jacobs Levy Equity Management sold 33,289 HOOKIPA Pharma shares in Q1 2022, an estimated $776K.
Jacobs Levy Equity Management first reported a position in HOOKIPA Pharma in Q3 2021 and held it in 2 quarters.
Jacobs Levy Equity Management's HOOKIPA Pharma position peaked at $1M in Q3 2021.
74 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2022, filed 16 May 2022.